Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Nerve Ultrasound as a Decisive Tool in Nonsystemic Vasculitic Neuropathy: A Case Report
Leupold D, Felbecker A, Tettenborn B, Hundsberger T. Nerve Ultrasound as a Decisive Tool in Nonsystemic Vasculitic Neuropathy: A Case Report. Case Rep Neurol 2016; 8:108-14.
May 25, 2016Nerve Ultrasound as a Decisive Tool in Nonsystemic Vasculitic Neuropathy: A Case Report
May 25, 2016Case Rep Neurol 2016; 8:108-14
Leupold Daniela, Felbecker Ansgar, Tettenborn Barbara, Hundsberger Thomas
[Reasons for General Practitioner Shortage – a Comparison Between France and Switzerland]
Cerny T, Rosemann T, Tandjung R, Corinne C. [Reasons for General Practitioner Shortage – a Comparison Between France and Switzerland]. Praxis (Bern 1994) 2016; 105:619-36.
May 25, 2016[Reasons for General Practitioner Shortage – a Comparison Between France and Switzerland]
May 25, 2016Praxis (Bern 1994) 2016; 105:619-36
Cerny Thomas, Rosemann Thomas, Tandjung Ryan, Corinne Chmiel
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
Chirgwin J, Colleoni M, Láng I, Neven P, Forbes J, Rabaglio M, Smith I, Goldhirsch A, Gelber R, Debled M, Ejlertsen B, Price K, Coates A, Giobbie-Hurder A, Thürlimann B. Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence. J Clin Oncol 2016; 34:2452-9.
May 23, 2016Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
May 23, 2016J Clin Oncol 2016; 34:2452-9
Chirgwin Jacquie H, Colleoni Marco, Láng István, Neven Patrick, Forbes John F, Rabaglio Manuela, Smith Ian, Goldhirsch Aron, Gelber Richard D, Debled Marc, Ejlertsen Bent, Price Karen N, Coates Alan S, Giobbie-Hurder Anita, Thürlimann Beat
Sterbebegleitung zwischen Psychotherapie und Spiritualität
Renz M. Sterbebegleitung zwischen Psychotherapie und Spiritualität - Psychotherapie in der Palliativmedizin. Psychotherapie im Alter 2016
May 20, 2016Sterbebegleitung zwischen Psychotherapie und Spiritualität
May 20, 2016Psychotherapie im Alter 2016
Renz Monika
A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction
Warschkow R, Cerny T, Schmied B, Gueller U, Thürlimann B, Jörger M. A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction. Br J Cancer 2016; 115:80-4.
May 17, 2016A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction
May 17, 2016Br J Cancer 2016; 115:80-4
Warschkow Rene, Cerny Thomas, Schmied Bruno, Gueller Ulrich, Thürlimann Beat, Jörger Markus
Reproducible Tissue Homogenization and Protein Extraction for Quantitative Proteomics Using MicroPestle-Assisted Pressure-Cycling Technology
Shao S, Guo T, Gross V, Lazarev A, Koh C, Gillessen Sommer S, Jörger M, Jochum W, Aebersold R. Reproducible Tissue Homogenization and Protein Extraction for Quantitative Proteomics Using MicroPestle-Assisted Pressure-Cycling Technology. J Proteome Res 2016; 15:1821-9.
May 10, 2016Reproducible Tissue Homogenization and Protein Extraction for Quantitative Proteomics Using MicroPestle-Assisted Pressure-Cycling Technology
May 10, 2016J Proteome Res 2016; 15:1821-9
Shao Shiying, Guo Tiannan, Gross Vera, Lazarev Alexander, Koh Ching Chiek, Gillessen Sommer Silke, Jörger Markus, Jochum Wolfram, Aebersold Ruedi
Follow-up practices for high-grade extremity Osteosarcoma
Rothermundt C, Seddon B, Dileo P, Strauss S, Coleman J, Briggs T, Haile S, Whelan J. Follow-up practices for high-grade extremity Osteosarcoma. BMC cancer 2016; 16:301.
May 6, 2016Follow-up practices for high-grade extremity Osteosarcoma
May 6, 2016BMC cancer 2016; 16:301
Rothermundt Christian, Seddon Beatrice M, Dileo Palma, Strauss Sandra J, Coleman Joanne, Briggs Timothy W, Haile Sarah R, Whelan Jeremy S
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
Lorente D, Crespo M, Flohr P, Mateo J, Altavilla A, Ferraldeschi R, Bianchini D, Attard G, Tunariu N, Miranda S, Riisnaes R, Omlin A, Zafeiriou Z, Nava-Rodrigues D, Pérez-López R, Pezaro C, Mehra N, Sheridan E, Figueiredo I, de Bono J. Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses. Clin Genitourin Cancer 2016; 14:485-493.
May 5, 2016Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
May 5, 2016Clin Genitourin Cancer 2016; 14:485-493
Lorente David, Crespo Mateus, Flohr Penny, Mateo Joaquin, Altavilla Amelia, Ferraldeschi Roberta, Bianchini Diletta, Attard Gerhardt, Tunariu Nina, Miranda Susana, Riisnaes Ruth, Omlin Aurelius, Zafeiriou Zafeiris, Nava-Rodrigues Daniel, Pérez-López Raquel, Pezaro Carmel, Mehra Niven, Sheridan Elizabeth, Figueiredo Ines, de Bono Johann
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Tombal B, Padhani A, Olmos D, Oh W, Nilsson S, Mastris K, Logothetis C, Lecouvet F, James N, Hussain M, Parker C, Rubin M, Tannock I, Sweeney C, Suzuki H, Sternberg C, Small E, Shore N, Sella A, Scher H, Schalken J, Heidenreich A, Gleave M, Smith M, Sartor O, Nelson P, Halabi S, Fizazi K, Efstathiou E, de Bono J, Attard G, Omlin A, Soule H, Akaza H, Fanti S, Eeles R, Drake C, De Santis M, Davis I, Daugaard G, Chinnaiyan A, Beltran H, Beer T, Gillessen Sommer S. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Ann Oncol 2016
May 2, 2016Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
May 2, 2016Ann Oncol 2016
Tombal B, Padhani A R, Olmos D, Oh W K, Nilsson S, Mastris K, Logothetis C J, Lecouvet F E, James N D, Hussain M, Parker C, Rubin M A, Tannock I F, Sweeney C J, Suzuki H, Sternberg C N, Small E J, Shore N D, Sella A, Scher H I, Schalken J A, Heidenreich A, Gleave M E, Smith M R, Sartor O, Nelson P S, Halabi S, Fizazi K, Efstathiou E, de Bono J S, Attard G, Omlin Aurelius, Soule H R, Akaza H, Fanti S, Eeles R A, Drake C G, De Santis M, Davis I D, Daugaard G, Chinnaiyan A M, Beltran H, Beer T M, Gillessen Sommer Silke
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
Koeberle D, Tschanz B, Rauch D, Peck-Radosavljevic M, Veilchenfeldt J, Lakatos G, Montemurro M, Wagner A, Buehlmann M, Horber D, Roth A, Saletti P, Samaras P, Ribi K, Li Q, Demeter G, Dufour J, Bodocky G. Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Ann Oncol 2016; 27:856-861.
May 2, 2016Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
May 2, 2016Ann Oncol 2016; 27:856-861
Koeberle D., Tschanz B., Rauch D., Peck-Radosavljevic M., Veilchenfeldt J., Lakatos G., Montemurro M., Wagner A.D., Buehlmann M., Horber Daniel, Roth A.D., Saletti P., Samaras P., Ribi K., Li Q., Demeter G., Dufour J.F., Bodocky G.
Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma
Moreau P, Ludwig H, Driessen C, Palumbo A, Facon T, Plesner T, Dimopoulos M, Sondergeld P, Sonneveld P, Zweegman S, Einsele H, van de Donk N, San Miguel J, Lokhorst H, Nahi H, Ben-Yehuda D, Cavo M, Cook G, Delforge M, Mateos M. Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma. Drugs 2016; 76:853-67.
May 1, 2016Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma
May 1, 2016Drugs 2016; 76:853-67
Moreau Philippe, Ludwig Heinz, Driessen Christoph, Palumbo Antonio, Facon Thierry, Plesner Torben, Dimopoulos Meletios, Sondergeld Pia, Sonneveld Pieter, Zweegman Sonja, Einsele Hermann, van de Donk Niels W C J, San Miguel Jesús, Lokhorst Henk, Nahi Hareth, Ben-Yehuda Dina, Cavo Michele, Cook Gordon, Delforge Michel, Mateos Maria-Victoria
Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
Soriano G, Florea B, Overkleeft H, den Dulk H, Everts B, Bader J, Meeuwenoord N, Besse A, Kraus M, Li N, Besse L, Driessen C. Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism. Leukemia 2016; 30:2198-2207.
Apr 27, 2016Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
Apr 27, 2016Leukemia 2016; 30:2198-2207
Soriano G P, Florea B I, Overkleeft H S, den Dulk H, Everts B, Bader J, Meeuwenoord N, Besse A, Kraus Marianne, Li N, Besse L, Driessen Christoph
[Neurological complications of anticancer treatments]
Hottinger A, Perez L, Hägele-Link S, Hundsberger T. [Neurological complications of anticancer treatments]. Rev Med Suisse 2016; 12:840-3.
Apr 27, 2016[Neurological complications of anticancer treatments]
Apr 27, 2016Rev Med Suisse 2016; 12:840-3
Hottinger Andreas F, Perez Lyat, Hägele-Link Stefan, Hundsberger Thomas
Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study
Neumair P, Krähenbühl S, Baty F, Brutsche M, Früh M, Hitz F, Ess S, Warschkow R, Joos L, Jörger M (2016). Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study - Abstrakt 169P.
Apr 15, 2016Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study
Apr 15, 2016European Lung Cancer Conference
Neumair P, Krähenbühl S, Baty Florent, Brutsche Martin, Früh Martin, Hitz Felicitas, Ess S, Warschkow Rene, Joos L, Jörger Markus
61PD 24h-blood profile gene expression biomarkers of the response to targeted therapy in advanced non-squamous non-small cell lung cancer (NSCLC)
Baty F, Jörger M, Früh M, Brutsche M. 61PD 24h-blood profile gene expression biomarkers of the response to targeted therapy in advanced non-squamous non-small cell lung cancer (NSCLC). J Thorac Oncol 2016; 11:S81.
Apr 15, 201661PD 24h-blood profile gene expression biomarkers of the response to targeted therapy in advanced non-squamous non-small cell lung cancer (NSCLC)
Apr 15, 2016J Thorac Oncol 2016; 11:S81
Baty Florent, Jörger Markus, Früh Martin, Brutsche Martin
[Meningioma: management of the most common brain tumour]
Hundsberger T, Surbeck W, Hader C, Putora P, Conen K, Roelcke U. [Meningioma: management of the most common brain tumour]. Praxis (Bern 1994) 2016; 105:445-51.
Apr 13, 2016[Meningioma: management of the most common brain tumour]
Apr 13, 2016Praxis (Bern 1994) 2016; 105:445-51
Hundsberger Thomas, Surbeck Werner, Hader Claudia, Putora Paul Martin, Conen Katrin, Roelcke Ulrich
Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis
Tarantino I, Warschkow R, Schmied B, Gueller U, Mieth M, Cerny T, Büchler M, Ulrich A. Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis. J Gastrointest Surg 2016; 20:1213-22.
Apr 11, 2016Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis
Apr 11, 2016J Gastrointest Surg 2016; 20:1213-22
Tarantino Ignazio, Warschkow Rene, Schmied Bruno, Gueller Ulrich, Mieth Markus, Cerny Thomas, Büchler Markus W, Ulrich Alexis
Anti-tumour activity of platinum compounds in advanced prostate cancer—a systematic literature review
Gillessen Sommer S, Omlin A, Hager S. Anti-tumour activity of platinum compounds in advanced prostate cancer—a systematic literature review. Annals of Oncology 2016; 27:975-984.
Apr 6, 2016Anti-tumour activity of platinum compounds in advanced prostate cancer—a systematic literature review
Apr 6, 2016Annals of Oncology 2016; 27:975-984
Gillessen Sommer Silke, Omlin Aurelius, Hager Sonja
Anti-tumour activity of platinum compounds in advanced prostate cancer-a systematic literature review
Hager S, Ackermann C, Jörger M, Gillessen S, Omlin A. Anti-tumour activity of platinum compounds in advanced prostate cancer-a systematic literature review. Ann Oncol 2016; 27:975-84.
Apr 6, 2016Anti-tumour activity of platinum compounds in advanced prostate cancer-a systematic literature review
Apr 6, 2016Ann Oncol 2016; 27:975-84
Hager S, Ackermann C J, Jörger Markus, Gillessen S, Omlin Aurelius
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial
Schwentner L, Janni W, Kiechle M, Härtl K, Weissenbacher T, Friedl T, Huober J, Scholz C, Wischnik A, Forstbauer H, Rack B, Eichler M, Singer S, Harbeck N, Fink V. Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial. Breast 2016; 27:69-77.
Apr 4, 2016Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial
Apr 4, 2016Breast 2016; 27:69-77
Schwentner Lukas, Janni Wolfgang, Kiechle Marion, Härtl Kristin, Weissenbacher Tobias, Friedl Thomas W P, Huober Jens, Scholz Christoph, Wischnik Arthur, Forstbauer Helmut, Rack Brigitte, Eichler Martin, Singer Susanne, Harbeck Nadia, Fink Visnja